Restoring conjunctival tolerance by topical nuclear factor–κB inhibitors reduces preservative-facilitated allergic conjunctivitis in mice

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 9, 2014, Pages 6116-6126

  Guzmán, Mauricio ^a   Sabbione, Florencia ^a   Gabelloni, María Laura ^a   Vanzulli, Silvia ^a   Trevani, AnalíA Silvina ^a   Giordano, Mirta Nilda ^a   Galletti, Jeremías Gastón ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

Allergic conjunctivitis; Benzalkonium chloride; Conjunctival epithelium; Conjunctival tolerance; NF B; Preservative

Indexed keywords

BENZALKONIUM CHLORIDE; GRANULOCYTE COLONY STIMULATING FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MYELOPEROXIDASE; OVALBUMIN; PRESERVATIVE; SYNAPTOTAGMIN I; BENZALKONIUM; CYTOKINE; LIPOPOLYSACCHARIDE; NF-KAPPAB INHIBITOR ALPHA;

ALLERGIC CONJUNCTIVITIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION ASSAY; CELL VIABILITY; COLORIMETRY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL LINE; CHEMICALLY INDUCED; COCULTURE; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; CYTOLOGY; DELAYED HYPERSENSITIVITY; DISEASE MODEL; DRUG EFFECTS; EPITHELIUM CELL; IMMUNOLOGY; METABOLISM; TOPICAL DRUG ADMINISTRATION; TOXICITY;

ADMINISTRATION, TOPICAL; ANIMALS; BENZALKONIUM COMPOUNDS; BLOTTING, WESTERN; CELL LINE; COCULTURE TECHNIQUES; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HYPERSENSITIVITY, DELAYED; I-KAPPA B PROTEINS; IMMUNE TOLERANCE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; NF-KAPPA B; OVALBUMIN; PRESERVATIVES, PHARMACEUTICAL; T-LYMPHOCYTES;

EID: 84908110469     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14075     Document Type: Article

References (45)

1. Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29:312–334.
2. Van der Valk R, Webers CAB, Schouten JSAG, Zeegers MP, Hendrikse F, Prins MH. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology. 2005;112:1177–1185.
3. Tomić M, Kaštelan S, Metež Soldo K, Salopek-Rabatić J. Influence of BAK-preserved prostaglandin analog treatment on the ocular surface health in patients with newly diagnosed primary open-angle glaucoma. Biomed Res Int. 2013;2013: 603782.
4. Katz G, Springs CL, Craven ER, Montecchi-Palmer M. Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAKfree travoprost. Clin Ophthalmol. 2010;4:1253–1261.
5. Buron N, Micheau O, Cathelin S, Lafontaine P-O, Creuzot- Garcher C, Solary E. Differential mechanisms of conjunctival cell death induction by ultraviolet irradiation and benzalkonium chloride. Invest Ophthalmol Vis Sci. 2006;47:4221–4230.
6. Sosne G, Albeiruti A-R, Hollis B, Siddiqi A, Ellenberg D, Kurpakus-Wheater M. Thymosin beta4 inhibits benzalkonium chloride-mediated apoptosis in corneal and conjunctival epithelial cells in vitro. Exp Eye Res. 2006;83:502–507.
7. De Saint Jean M. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci. 1999;40:619–630.
8. Epstein SP, Chen D, Asbell PA. Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther. 2009;25:415–424.
9. Galletti JG, Gabelloni ML, Morande PE, et al. Benzalkonium chloride breaks down conjunctival immunological tolerance in a murine model. Mucosal Immunol. 2013;6:24–34.
10. Egan RM. In vivo behavior of peptide-specific T cells during mucosal tolerance induction: antigen introduced through the mucosa of the conjunctiva elicits prolonged antigen-specific T cell priming followed by anergy. J Immunol. 2000;164:4543–4550.
11. Seo KY, Han SJ, Cha H-R, et al. Eye mucosa: an efficient vaccine delivery route for inducing protective immunity. J Immunol. 2010;185:3610–3619.
12. Akdis CA, Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol. 2009;123:735–746.
13. Macaubas C, DeKruyff RH, Umetsu DT. Respiratory tolerance in the protection against asthma. Curr Drug Targets Inflamm Allergy. 2003;2:175–186.
14. Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol. 2011;127:18–27.
15. Swamy M, Jamora C, Havran W, Hayday A. Epithelial decision makers: in search of the /’epimmunome/’. Nat Immunol. 2010;11:656–665.
16. Wullaert A, Bonnet MC, Pasparakis M. NF-κB in the regulation of epithelial homeostasis and inflammation. Cell Res. 2011;21: 146–158.
17. Pasparakis M. Role of NF-κB in epithelial biology. Immunol Rev. 2012;246:346–358.
18. Vroling AB, Jonker MJ, Luiten S, Breit TM, Fokkens WJ, van Drunen CM. Primary nasal epithelium exposed to house dust mite extract shows activated expression in allergic individuals. Am J Respir Cell Mol Biol. 2008;38:293–299.
19. Van Hove CL, Moerloose K, Maes T, Joos GF, Tournoy KG. Cigarette smoke enhances Th-2 driven airway inflammation and delays inhalational tolerance. Respir Res. 2008;9:42.
20. Lee KS, Jin SM, Kim SS, Lee YC. Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol. 2004;113:902–909.
21. Ogawa H, Azuma M, Muto S, et al. IκB kinase β inhibitor IMD- 0354 suppresses airway remodelling in a Dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma. Clin Exp Allergy. 2011;41:104–115.
22. Neurath MF, Pettersson S, Meyer zum Büschenfelde KH, Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med. 1996;2: 998–1004.
23. El-Hashim AZ, Renno WM, Abduo HT, Jaffal SM, Akhtar S, Benter IF. Effect of inhibition of the ubiquitin-proteasomesystem and IκB kinase on airway inflammation and hyperresponsiveness in a murine model of asthma. Int J Immunopathol Pharmacol. 2011;24:33–42.
24. Yuspa SH, Hawley-Nelson P, Koehler B, Stanley JR. A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res. 1980;40:4694–4703.
25. Galletti JG, Cañones C, Morande PE, et al. Chronic lymphocytic leukemia cells bind and present the erythrocyte protein band 3: possible role as initiators of autoimmune hemolytic anemia. J Immunol. 2008;181:3674–3683.
26. Li D-Q, Zhang L, Pflugfelder SC, et al. Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4- dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways. J Allergy Clin Immunol. 2011;128:1318–1325.e2.
27. Kawakita T, Espana EM, He H, Yeh L-K, Liu C-Y, Tseng SCG. Calcium-induced abnormal epidermal-like differentiation in cultures of mouse corneal-limbal epithelial cells. Invest Ophthalmol Vis Sci. 2004;45:3507–3512.
28. Zhou Y. Modulation of the canonical Wnt pathway by benzalkonium chloride in corneal epithelium. Exp Eye Res. 2011;93:355–362.
29. Brasnu E, Brignole-Baudouin F, Riancho L, Warnet JM, Baudouin C. Comparative study on the cytotoxic effects of benzalkonium chloride on the Wong-Kilbourne derivative of Chang conjunctival and IOBA-NHC cell lines. Mol Vis. 2008; 14:394–402.
30. Weber CK, Liptay S, Wirth T, Adler G, Schmid RM. Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology. 2000;119:1209–1218.
31. Hayakawa M, Miyashita H, Sakamoto I, et al. Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J. 2003;22:3356–3366.
32. Baudouin C, Hamard P, Liang H, Creuzot-Garcher C, Bensoussan L, Brignole F. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology. 2004;111:2186–2192.
33. Nishioka K, Katayama I, Kobayashi Y. Ia antigen expressed by keratinocytes can be the molecule of antigen presentation in contact sensitivity. J Invest Dermatol. 1987;88:694–698.
34. Gaspari AA, Katz SI. Induction and functional characterization of class II MHC (Ia) antigens on murine keratinocytes. J Immunol. 1988;140:2956–2963.
35. Droy-Lefaix MT, Bueno L, Caron P, Belot E, Roche O. Ocular inflammation and corneal permeability alteration by benzalkonium chloride in rats: a protective effect of a myosin light chain kinase inhibitor. Invest Ophthalmol Vis Sci. 2013;54: 2705–2710.
36. Di Sabatino A, Biancheri P, Rovedatti L, MacDonald TT, Corazza GR. New pathogenic paradigms in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:368–371.
37. Paimela T, Ryhänen T, Kauppinen A, Marttila L, Salminen A, Kaarniranta K. The preservative polyquaternium-1 increases cytoxicity and NF-kappaB linked inflammation in human corneal epithelial cells. Mol Vis. 2012;18:1189–1196.
38. Kode A, Yang S-R, Rahman I. Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir Res. 2006;7:132.
39. Deppong CM, Xu J, Brody SL, Green JM. Airway epithelial cells suppress T cell proliferation by an IFNc/STAT1/TGFb-dependent mechanism. Am J Physiol Lung Cell Mol Physiol. 2012; 302:L167–L173.
40. Cruickshank SM, McVay LD, Baumgart DC, Felsburg PJ, Carding SR. Colonic epithelial cell mediated suppression of CD4 T cell activation. Gut. 2004;53:678–684.
41. Wang H, Su Z, Schwarze J. Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation. Thorax. 2009;64:283–290.
42. Mayer AK, Bartz H, Fey F, Schmidt LM, Dalpke AH. Airway epithelial cells modify immune responses by inducing an antiinflammatory microenvironment. Eur J Immunol. 2008;38: 1689–1699.
43. Gugasyan R, Voss A, Varigos G, et al. The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms. Mol Cell Biol. 2004;24:5733–5745.
44. Lind MH, Rozell B, Wallin RPA, et al. Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition. Proc Natl Acad Sci U S A. 2004;101:4972–4977.
45. Stern ME, Schaumburg CS, Pflugfelder SC. Dry eye as a mucosal autoimmune disease. Int Rev Immunol. 2013;32:19–41.